课题基金 / 基金详情

项目摘要

项目成果

Donal Luse的其他基金

相似基金

相关文献

中文摘要
翻译
越来越明显的是,RNA聚合酶II从起始到转录延伸的转变是一个过程
英文摘要
It is increasingly evident that the transition from initiation to transcript elongation by RNA polymerase II is a major regulatory checkpoint in eukaryotic gene expression. During the current support period our laboratory has made significant advances in characterizing this transition. We have devised a working model for promoter clearance, the initial step in this process. Our clearance model includes the novel concept of an important role for transcript initiation factors. We have also demonstrated that a distinct postclearance transition occurs from 25-35 bases downstream of transcription start. Our analysis of the ability of RNA polymerase II to pass through the postclearance stage has suggested new insights into mechanisms through which polymerase can be trapped at this point in transcription. In the current application, we propose four specific aims, through which we will (i) test our initial models for the clearance and postclearance transitions (ii) determine the roles of individual transcription factors in these transitions, and (iii)identify underlying DMA sequences which have important effects on these transitions. Relevance to Public Health: Many genes whose correct expression is essential for human health are controlled through the extended pausing of the transcriptional machinery at a point just after the transcription of genetic information has initiated. It is not currently known how these "regulated gates" operate. In order to ultimately manipulate these gates for the benefit of human health, it is essential to uncover the molecular mechanisms involved. The research proposed here is aimed at providing this knowledge. The clearance and postclearance transitions which we study are test tube models for the regulatory points observed in the cell.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
Abortive initiation is increased only for the weakest members of a set of down mutants of the adenovirus 2 major late promoter.
仅对于腺病毒2主要晚期启动子的一组下调突变体中最弱的成员,流产起始增加。
DOI: --
发表时间: 1991
期刊: The Journal of biological chemistry
影响因子: --
作者: [Jacob,GA, Luse,SW, Luse,DS]
通讯作者: Luse,DS
Variations in template protection by the RNA polymerase II transcription complex during the initiation process.
起始过程中 RNA 聚合酶 II 转录复合物对模板保护的变化。
DOI: 10.1128/mcb.7.10.3371-3379.1987
发表时间: 1987
期刊: Molecular and cellular biology
影响因子: 5.3
作者: [Cai,H, Luse,DS]
通讯作者: Luse,DS
DOI: 10.1016/s0021-9258(19)75926-2
发表时间: 1987-01
期刊: The Journal of biological chemistry
影响因子: --
作者: [H. Cai;D. Luse]
通讯作者: H. Cai;D. Luse
RNA polymerase II elongation complexes paused after the synthesis of 15- or 35-base transcripts have different structures.
在合成 15 或 35 碱基转录物后暂停的 RNA 聚合酶 II 延伸复合物具有不同的结构。
DOI: 10.1128/mcb.11.3.1508-1522.1991
发表时间: 1991
期刊: Molecular and cellular biology
影响因子: 5.3
作者: [Linn,SC, Luse,DS]
通讯作者: Luse,DS
共 14 条
    The effect of nucleosomes on the earliest stages of RNA polymerase II transcription
    TRANSCRIPTION OF CHROMATIN TEMPLATES
    • 批准号:
      6526056
    • 项目类别:
    • 资助金额:
      $29.3万
    • 财政年份:
      1999
    • 负责人:
      Donal Luse
    • 依托单位:
    TRANSCRIPTION OF CHROMATIN TEMPLATES
    • 批准号:
      2883938
    • 项目类别:
    • 资助金额:
      $27.25万
    • 财政年份:
      1999
    • 负责人:
      Donal Luse
    • 依托单位:
    TRANSCRIPTION OF CHROMATIN TEMPLATES
    • 批准号:
      6182028
    • 项目类别:
    • 资助金额:
      $28.0万
    • 财政年份:
      1999
    • 负责人:
      Donal Luse
    • 依托单位:
    海外基金